Published in World J Gastroenterol on February 28, 2014
Electric light, particularly at night, disrupts human circadian rhythmicity: is that a problem? Philos Trans R Soc Lond B Biol Sci (2015) 0.85
Effects of Per2 overexpression on growth inhibition and metastasis, and on MTA1, nm23-H1 and the autophagy-associated PI3K/PKB signaling pathway in nude mice xenograft models of ovarian cancer. Mol Med Rep (2016) 0.75
PI3K-PTEN dysregulation leads to mTOR-driven upregulation of the core clock gene BMAL1 in normal and malignant epithelial cells. Oncotarget (2016) 0.75
The Clock Is Ticking: Countdown to Metastases. PLoS Genet (2016) 0.75
Upregulation of WEE1 is a potential prognostic biomarker for patients with colorectal cancer. Oncol Lett (2017) 0.75
Cancer/testis antigen PIWIL2 suppresses circadian rhythms by regulating the stability and activity of BMAL1 and CLOCK. Oncotarget (2017) 0.75
Cancer statistics, 2013. CA Cancer J Clin (2013) 84.72
PERIOD2::LUCIFERASE real-time reporting of circadian dynamics reveals persistent circadian oscillations in mouse peripheral tissues. Proc Natl Acad Sci U S A (2004) 12.43
Role of the CLOCK protein in the mammalian circadian mechanism. Science (1998) 10.03
The orphan nuclear receptor REV-ERBalpha controls circadian transcription within the positive limb of the mammalian circadian oscillator. Cell (2002) 9.92
Colorectal cancer. Lancet (2010) 8.36
Mammalian Cry1 and Cry2 are essential for maintenance of circadian rhythms. Nature (1999) 7.86
The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell (2002) 6.05
Control mechanism of the circadian clock for timing of cell division in vivo. Science (2003) 5.92
Closing the circadian loop: CLOCK-induced transcription of its own inhibitors per and tim. Science (1998) 5.72
The molecular clock mediates leptin-regulated bone formation. Cell (2005) 3.88
The circadian gene per1 plays an important role in cell growth and DNA damage control in human cancer cells. Mol Cell (2006) 2.71
CLOCK-mediated acetylation of BMAL1 controls circadian function. Nature (2007) 2.65
Coupling of human circadian and cell cycles by the timeless protein. Mol Cell Biol (2005) 2.24
The canonical Wnt signalling pathway and its APC partner in colon cancer development. Gut (2006) 1.86
The circadian clock component BMAL1 is a critical regulator of p21WAF1/CIP1 expression and hepatocyte proliferation. J Biol Chem (2007) 1.79
The many faces of c-MYC. Arch Biochem Biophys (2003) 1.74
Over-expression of circadian clock gene Bmal1 affects proliferation and the canonical Wnt pathway in NIH-3T3 cells. Cell Biochem Funct (2012) 1.57
Direct association between mouse PERIOD and CKIepsilon is critical for a functioning circadian clock. Mol Cell Biol (2004) 1.49
High-resolution time course analysis of gene expression from pituitary. Cold Spring Harb Symp Quant Biol (2007) 1.45
MicroRNA-based therapeutics for cancer. BioDrugs (2009) 1.45
Regulation of BMAL1 protein stability and circadian function by GSK3beta-mediated phosphorylation. PLoS One (2010) 1.44
Global co-distribution of light at night (LAN) and cancers of prostate, colon, and lung in men. Chronobiol Int (2009) 1.40
The Wnt/beta-catenin signaling pathway targets PPARgamma activity in colon cancer cells. Proc Natl Acad Sci U S A (2005) 1.32
DEC1 modulates the circadian phase of clock gene expression. Mol Cell Biol (2008) 1.31
Circadian proteins in the regulation of cell cycle and genotoxic stress responses. Trends Cell Biol (2007) 1.30
The circadian gene NPAS2, a putative tumor suppressor, is involved in DNA damage response. Mol Cancer Res (2008) 1.27
Circulating melatonin and the risk of breast and endometrial cancer in women. Cancer Lett (2008) 1.25
Regulation of genes of the circadian clock in human colon cancer: reduced period-1 and dihydropyrimidine dehydrogenase transcription correlates in high-grade tumors. Cancer Res (2007) 1.24
Altered expression of circadian clock genes in head and neck squamous cell carcinoma. Tumour Biol (2011) 1.21
Treatment of metastatic colorectal cancer. Semin Oncol (2011) 1.20
Cell "circadian" cycle: new role for mammalian core clock genes. Cell Cycle (2009) 1.14
Mammalian TIMELESS is required for ATM-dependent CHK2 activation and G2/M checkpoint control. J Biol Chem (2009) 1.14
Expression of circadian genes correlates with liver metastasis and outcomes in colorectal cancer. Oncol Rep (2011) 1.12
c-Myc overexpression sensitises colon cancer cells to camptothecin-induced apoptosis. Br J Cancer (2003) 1.12
Deletion of the PER3 gene on chromosome 1p36 in recurrent ER-positive breast cancer. J Clin Oncol (2010) 1.10
Clock gene expression levels and relationship with clinical and pathological features in colorectal cancer patients. Chronobiol Int (2011) 1.08
Expression of DNA double-strand break repair proteins ATM and BRCA1 predicts survival in colorectal cancer. Clin Cancer Res (2006) 1.08
Period 2 mutation accelerates ApcMin/+ tumorigenesis. Mol Cancer Res (2008) 1.05
Differential gene expression in colon carcinoma cells and tissues detected with a cDNA array. Int J Cancer (1999) 1.00
Functional polymorphisms of circadian positive feedback regulation genes and clinical outcome of Chinese patients with resected colorectal cancer. Cancer (2011) 0.94
Loss of expression of the double strand break repair protein ATM is associated with worse prognosis in colorectal cancer and loss of Ku70 expression is associated with CIN. Oncotarget (2012) 0.94
Mutations in the circadian gene CLOCK in colorectal cancer. Mol Cancer Res (2010) 0.93
Effects of the biological clock gene Bmal1 on tumour growth and anti-cancer drug activity. J Biochem (2010) 0.93
Per2 inhibits k562 leukemia cell growth in vitro and in vivo through cell cycle arrest and apoptosis induction. Pathol Oncol Res (2009) 0.92
Beta-catenin induces beta-TrCP-mediated PER2 degradation altering circadian clock gene expression in intestinal mucosa of ApcMin/+ mice. J Biochem (2008) 0.90
A meta-analysis of the prevalence of somatic mutations in the hMLH1 and hMSH2 genes in colorectal cancer. Colorectal Dis (2012) 0.89
New reporter system for Per1 and Bmal1 expressions revealed self-sustained circadian rhythms in peripheral tissues. Genes Cells (2006) 0.88
An association between clock genes and clock-controlled cell cycle genes in murine colorectal tumors. Int J Cancer (2012) 0.88
Clock-controlled mir-142-3p can target its activator, Bmal1. BMC Mol Biol (2012) 0.88
Effect of constant light on DMBA mammary tumorigenesis in rats. Cancer Lett (2000) 0.86
Association of the clock genes polymorphisms with colorectal cancer susceptibility. J Surg Oncol (2013) 0.85
Cryptochrome 1 overexpression correlates with tumor progression and poor prognosis in patients with colorectal cancer. PLoS One (2013) 0.85
Expression of circadian clock gene human Period2 (hPer2) in human colorectal carcinoma. World J Surg Oncol (2011) 0.85
A role for the PERIOD:PERIOD homodimer in the Drosophila circadian clock. PLoS Biol (2009) 0.81
Alteration of the DNA damage response in colorectal tumor progression. Hum Pathol (2013) 0.78
Circadian variation of dihydropyrimidine dehydrogenase mRNA expression in leukocytes and serum cortisol levels in patients with advanced gastrointestinal carcinomas compared to healthy controls. J Cancer Res Clin Oncol (2001) 0.76
[Dihydropyrimidine deshydrogenase (DPD): rhythm and consequences]. Pathol Biol (Paris) (2005) 0.76